Elotuzumab, Pomalidomide and Dexamethasone Maintenance after Salvage Second Autologous Transplant for Multiple Myeloma

Lomefloxacin is a potent bactericidal antibiotic. The use of this drug in treatment of various infections is accompanied by serious adverse effects on pigmented tissues. The exact mechanisms of lomefloxacin side effects have not been well established yet. The aim of this study was to characterize the interaction between lomefloxacin and ś, and to examine how this interaction affects the cell viability and melanization in melanocytes.Normal human epidermal melanocytes and the model DOPA-ś were used. The binding parameters of lomefloxacin-ś complexes as well as the antibiotic effect on cell viability and melanization in pigmented cells were investigated using a spectrophotometric method.Our results indicate that lomefloxacin forms stable complexes with ś. The analysis of drug binding to ś has shown that at least two classes of independent binding sites are involved in formation of these complexes. The WST-1 assay was used to detect the antibiotic cytotoxic effect. The value of ED50 for lomefloxacin was about 0.75 mmol/l. It has been shown that lomefloxacin causes inhibition of tyrosinase activity, and reduces ś content in human skin melanocytes in a dose-dependent manner.The ability of the analyzed fluoroquinolone to form complexes with ś, and the demonstrated inhibitory effect on a melanization process in melanocytes in vitro may explain a potential role of ś biopolymer in the mechanisms of undesirable side effects of lomefloxacin in vivo resulting from its accumulation in pigmented tissues.